Binging Knowledge to Bear: Challenges for Decision Support Databases

D. Maier,Mary Edie Meredith,L. Shapiro

Abstract:

What problem does this paper attempt to address?

Injectable therapeutic peptides-an adjunct to regenerative medicine and sports performance?

Mikalyn T DeFoor,Travis J Dekker

DOI: https://doi.org/10.1016/j.arthro.2024.09.005

2024-09-10

Abstract:High level athletes and bodybuilders are constantly seeking novel therapies to enhance recovery and expedite return from injury-injectable peptides are a new and trending therapy that may be the wave of the future of in the realm of regenerative medicine research in treating joint injuries and osteoarthritis. Very early in vivo research of the pharmacokinetics suggests the possibility of Body Protection Compound 157 (BPC-157) appears to be at the forefront of therapeutic peptides with early demonstration of these experimental peptides optimizing endurance training, metabolism, recovery and tissue repair. While uUnregulated, yetand readily available for purchase over the internet, there is scarce orthopaedic literature investigating the clinical use and outcomes of these therapeutic peptides in tendon, muscle and cartilage injury. However, this has not slowed the recent exponential growth of the multi-billion-dollar industry in development of therapeutic peptides. As orthopaedic surgeons and team physicians, we should stay up-to-date with the latest pharmacokinetic, safety, ethical, and legal profilesregulations regarding synthetic peptide supplementation for injury recovery and sports performance optimization from our elite athletes to our fitness fanatics as these patients will continue to seek the latest and greatest in treatment options and will be approaching us with questions on their results, risks and benefits..
Peptide-Based Biomaterials for Bone and Cartilage Regeneration

Kausik Kapat,Sakshi Kumbhakarn,Rahul Sable,Prashil Gondane,Shruti Takle,Pritiprasanna Maity

DOI: https://doi.org/10.3390/biomedicines12020313

IF: 4.757

2024-01-29

Biomedicines

Abstract:The healing of osteochondral defects (OCDs) that result from injury, osteochondritis, or osteoarthritis and bear lesions in the cartilage and bone, pain, and loss of joint function in middle- and old-age individuals presents challenges to clinical practitioners because of non-regenerative cartilage and the limitations of current therapies. Bioactive peptide-based osteochondral (OC) tissue regeneration is becoming more popular because it does not have the immunogenicity, misfolding, or denaturation problems associated with original proteins. Periodically, reviews are published on the regeneration of bone and cartilage separately; however, none of them addressed the simultaneous healing of these tissues in the complicated heterogeneous environment of the osteochondral (OC) interface. As regulators of cell adhesion, proliferation, differentiation, angiogenesis, immunomodulation, and antibacterial activity, potential therapeutic strategies for OCDs utilizing bone and cartilage-specific peptides should be examined and investigated. The main goal of this review was to study how they contribute to the healing of OCDs, either alone or in conjunction with other peptides and biomaterials.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Peptides for Targeting Chondrogenic Induction and Cartilage Regeneration in Osteoarthritis

Hsiu-Jung Liao,Hui-Ting Chen,Chih-Hung Chang

DOI: https://doi.org/10.1177/19476035241276406

IF: 3.117

2024-09-20

Cartilage

Abstract:CARTILAGE, Ahead of Print. ObjectsOsteoarthritis (OA) is a widespread degenerative joint condition commonly occurring in older adults. Currently, no disease-modifying drugs are available, and safety concerns associated with commonly used traditional medications have been identified. In this review, a significant portion of research in this field is concentrated on cartilage, aiming to discover methods to halt cartilage breakdown or facilitate cartilage repair.MethodsResearchers have mainly investigated the cartilage, seeking methods to promote its repair. This review focuses on peptide-based molecules known for their ability to selectively bind to growth factor cytokines and components of the cartilage extracellular matrix.ResultsChondroinductive peptides, synthetically producible, boast superior reproducibility, stability, modifiability, and yield efficiency over natural biomaterials. This review outlines a chondroinductive peptide design, molecular mechanisms, and their application in cartilage tissue engineering and also compares their efficacy in chondrogenesis in vitro and in vivo.ConclusionsIn this paper, we will summarize the application of peptides engineered to regenerate cartilage by acting as scaffolds, functional molecules, or both and discuss additional possibilities for peptides. This review article provides an overview of our current understanding of chondroinductive peptides for treating OA-affected cartilage and explores the delivery systems used for regeneration. These advancements may hold promise for enhancing or even replacing current treatment methodologies.

orthopedics
Therapeutic applications of biological macromolecules and scaffolds for skeletal muscle regeneration: A review

Syed Sayeed Ahmad,Khurshid Ahmad,Jeong Ho Lim,Sibhghatulla Shaikh,Eun Ju Lee,Inho Choi

DOI: https://doi.org/10.1016/j.ijbiomac.2024.131411

IF: 8.2

2024-04-19

International Journal of Biological Macromolecules

Abstract:Skeletal muscle (SM) mass and strength maintenance are important requirements for human well-being. SM regeneration to repair minor injuries depends upon the myogenic activities of muscle satellite (stem) cells. However, losses of regenerative properties following volumetric muscle loss or severe trauma or due to congenital muscular abnormalities are not self-restorable, and thus, these conditions have major healthcare implications and pose clinical challenges. In this context, tissue engineering based on different types of biomaterials and scaffolds provides an encouraging means of structural and functional SM reconstruction. In particular, biomimetic (able to transmit biological signals) and several porous scaffolds are rapidly evolving. Several biological macromolecules/biomaterials (collagen, gelatin, alginate, chitosan, and fibrin etc.) are being widely used for SM regeneration. However, available alternatives for SM regeneration must be redesigned to make them more user-friendly and economically feasible with longer shelf lives. This review aimed to explore the biological aspects of SM regeneration and the roles played by several biological macromolecules and scaffolds in SM regeneration in cases of volumetric muscle loss.

polymer science,biochemistry & molecular biology,chemistry, applied
The Use of Platelet-Rich Plasma and Stem Cell Injections in Musculoskeletal Injuries

Nicole Schneider,Michael Sinnott,Nikita Patel,Roody Joseph

DOI: https://doi.org/10.7759/cureus.59970

2024-05-09

Cureus

Abstract:Injuries to the musculoskeletal (MSK) system can have a significant impact on an individual's activities of daily living, as this multifunctional unit is associated with physical movement. Treatment of MSK injuries often involves corticosteroid injections, supplements, pharmaceutical agents, and/or surgery. While these approaches have been shown to be effective for some patients over both the short and long term, they can be associated with limited relief, adverse effects, and/or decreases in activities of daily living. An unmet need exists to develop and/or implement more effective treatment approaches for MSK injuries. Treatment options being explored include platelet-rich plasma (PRP) and stem cell injections. This review outlines the current state of research evaluating PRP and stem cell injections in the treatment of various MSK injuries. A literature search was conducted using the PubMed database to identify the relevant published articles related to the use of PRP and/or stem cell injections for the treatment of MSK and cartilage injuries. PRP and stem cell injections have been shown to improve an individual's quality of life (QOL) and are associated with fewer side effects as compared to invasive standards of care in multiple MSK injuries such as plantar fasciitis, Achilles tendinopathy, acute muscle and tendon tears, ligament injuries, chondral and medial collateral ligament (MCL) knee injuries and arthritis, rotator cuff lesions, and avascular femoral necrosis. Specifically, these studies on PRP and stem cell injections suggest that both approaches are associated with a quicker return to activities of daily living while providing longer lasting relief without significant adverse events. The studies reviewed demonstrated PRP and stem cell approaches to be effective and safe for the treatment of certain MSK injuries, but as standardized protocols were not utilized across studies in the discussion of similar injuries, it was therefore difficult to compare their efficacy and safety. As such, further research is warranted to establish standardized research protocols across MSK injury studies to gain further insight into the efficacy, safety, and durability of PRP and stem cell injections.
Therapeutic Sources of Skeletal Muscle Regeneration from Volumetric Muscle Loss: A Narrative Review

Kwangjun Lee,Wonil Park,Kwang-Seok Hong

DOI: https://doi.org/10.15857/ksep.2022.00311

2022-08-31

Exercise Science

Abstract:PURPOSE: Minor skeletal muscle injuries can be repaired, but more extensive volumetric muscle loss (VML) leads to a permanent functional disability with ambiguous therapeutic outcomes, and reconstructive surgical procedures are constrained by donor tissue scarcity. This review assessed the considerable attention paid to biomaterials in healing damaged skeletal muscle.METHODS: A comprehensive search in PubMed, Web of Science, Google Scholar, and Wiley Online Library was conducted to obtain previous studies exploring the state of biocompatible tissue scaffolds for VML recovery.RESULTS: By regenerating the function of damaged skeletal muscle, tissue-engineered skeletal muscle construction could revolutionize the treatment of VML. However, transporting cells into the wounded muscle location presents a significant challenge because it may result in unfavorable immunological reactions. The development and validation of several biomaterials with varying physical and chemical natures to treat various muscle injuries have recently been undertaken to overcome this problem. This review discusses the relative benefits of satellite cells (SC), the most prevalent skeletal muscle stem cells employed to seed scaffolds.CONCLUSIONS: Biomaterials can be used with skeletal muscle stem cells and growth factors to repair VML because of their customizable and desirable physicochemical qualities. Owing to the capacity of SCs for self-renewal and their undifferentiated state, these cells are excellent candidates for cell therapy. A large gap exists between understanding SC behavior and how it can be used to repair and regenerate human skeletal muscle tissue. Thus, this review sought to portray the current knowledge on the lifespan of SCs and their involvement in exercise-induced muscle regeneration and hypertrophy.
Swarm optimized organizing map (SWOM): A swarm intelligence basedoptimization of self-organizing map

Akın Özçift,Mehmet Kaya,Arif Gülten,Mustafa Karabulut

DOI: https://doi.org/10.1016/j.eswa.2009.02.051

IF: 8.5

2009-09-01

Expert Systems with Applications

Abstract:
Preclinical research studies for treating severe muscular injuries: focus on tissue-engineered strategies

Omar Alheib,Il Keun Kwon,Lucília P. da Silva,Rui L. Reis,Vitor M. Correlo

DOI: https://doi.org/10.1016/j.tibtech.2022.09.010

2023-04-13

Trends in Biotechnology

Abstract:Severe skeletal muscle injuries are a lifelong trauma with limited medical solutions. Significant progress has been made in developing in vitro surrogates for treating such trauma. However, more attention is needed when translating these approaches to the clinic. In this review, we survey the potential of tissue-engineered surrogates in promoting muscle healing, by critically analyzing data from recent preclinical models. The therapeutic advantages provided by a combination of different biomaterials, cell types, and biochemical mediators are discussed. Current therapies on muscle healing are also summarized, emphasizing their main advantages and drawbacks. We also discuss previous and ongoing clinical trials as well as highlighting future directions for the field.

biotechnology & applied microbiology
The perio-endo question: differential diagnosis.

G. Harrington

DOI: https://doi.org/10.1016/s0011-8532(22)03177-9

1979-10-01

Dental Clinics of North America

Abstract:
Cell-based therapy in soft tissue sports injuries of the knee: a systematic review

Nardeen Kader,Vipin Asopa,Kwaku Baryeh,David Sochart,Nicola Maffulli,Deiary Kader

DOI: https://doi.org/10.1080/14712598.2021.1872538

Abstract:Introduction: An ever-increasing number of clinics are offering purportedly 'regenerative' stem-cell treatments, although cell-based therapies may not primarily act as stem cells and have shown the ability to regenerate end-target tissues in some clinical studies only. We aim to systematically review the evidence for their use in soft-tissue sports injuries of the knee. Areas covered: A search for articles pertaining to the use of preparations of, or containing, mesenchymal stem cells (MSCs) in human subjects in sports knee injuries yielded 14 relevant results for inclusion after screening: 7 used cultured MSCs, 5 bone marrow concentrate (BMC), and the remaining 2 evaluated stromal vascular fraction (SVF) and tenocyte-like-cells. Most studies were level 3 or lower (n = 9). Expert opinion: There is insufficient high-quality evidence for the use of cell-based therapies that demonstrates either ligamentous or tendinous healing, meniscal volume restoration, or post-traumatic osteoarthritis amelioration/regression. Methods of cell harvesting, preparation, and application are highly heterogenous. Efforts should be directed toward standardization of protocols and their reporting, starting with more basic scientific investigations of MSCs and their niche, as well as rigorous, large clinical RCTs adhering to the reporting principles set out by recent expert consensus.
Gelatin Methacryloyl Hydrogels for Musculoskeletal Tissue Regeneration

Yang-Hee Kim,Jonathan I Dawson,Richard O C Oreffo,Yasuhiko Tabata,Dhiraj Kumar,Conrado Aparicio,Isha Mutreja

DOI: https://doi.org/10.3390/bioengineering9070332

2022-07-21

Abstract:Musculoskeletal disorders are a significant burden on the global economy and public health. Hydrogels have significant potential for enhancing the repair of damaged and injured musculoskeletal tissues as cell or drug delivery systems. Hydrogels have unique physicochemical properties which make them promising platforms for controlling cell functions. Gelatin methacryloyl (GelMA) hydrogel in particular has been extensively investigated as a promising biomaterial due to its tuneable and beneficial properties and has been widely used in different biomedical applications. In this review, a detailed overview of GelMA synthesis, hydrogel design and applications in regenerative medicine is provided. After summarising recent progress in hydrogels more broadly, we highlight recent advances of GelMA hydrogels in the emerging fields of musculoskeletal drug delivery, involving therapeutic drugs (e.g., growth factors, antimicrobial molecules, immunomodulatory drugs and cells), delivery approaches (e.g., single-, dual-release system), and material design (e.g., addition of organic or inorganic materials, 3D printing). The review concludes with future perspectives and associated challenges for developing local drug delivery for musculoskeletal applications.
The use of amniotic tissue-derived products in orthopedic surgery: A narrative review

Jessica Forbes,Garrett R Jackson,Derrick M Knapik,Justin T Childers,Connor Donley,Nino Coutelle,Vani J Sabesan

DOI: https://doi.org/10.1016/j.injury.2024.111901

IF: 2.687

Injury

Abstract:Amniotic-derived products have been used for decades in various medical subspecialties and have proven to be a safe method of allograft tissue transplantation. These products have shown promising preclinical and early clinical results in the treatment of tendon/ligament injuries, cartilage defects, and osteoarthritis. The therapeutic benefits of amniotic-derived products are likely due to intrinsic properties, such as their structure as an extracellular matrix and concentration of growth factors, as well as anti-inflammatory, antifibrotic, and antimicrobial molecules. We performed a narrative review, evaluating the pre-clinical and clinical use of amniotic-derived products in musculoskeletal injuries such as osteoarthritis, Achilles tendinopathy, plantar fasciitis, lateral epicondylitis, chronic stenosing tenosynovitis, and nerve, cartilage and tendon repair or reconstruction, along with fracture healing treatment. In vitro and pre-clinical studies using amniotic-derived products for orthopedic treatments have shown promising results and provide the foundation for further human trials to be conducted. With the rise of commercially available biologics, incorporating amniotic products into orthopedic practice is becoming more accessible, while further studies investigating long-term outcomes and potential adverse events are necessary.
Peptide-Based Functional Nanomaterials for Soft-Tissue Repair

Surendra Tripathy,Dilip Kumar Patel,Roohi Kesharwani,Vikas Kumar

DOI: https://doi.org/10.1201/9781003140108-5

2021-10-27

Abstract:Soft-tissue injury is characterized by damage of muscles, ligaments or tendons, blood vessels, etc., which is a common form of injury reported worldwide. The global soft-tissue repair market is growing at rate of approximately 7.5%; still research is going on to find sustainable treatment options ranging right from drug-based therapies to scaffold-based treatments. By exploiting the versatile nature of nanomaterials peptide/protein-based nanomaterials (PBNMs) may prove to be an efficient soft-tissue repair method. PBNMs are getting prime importance as these materials can mimic endogenous full-length peptides both structurally and functionally. These can enhance cell attachment, induce several cellular signaling pathways, and promote natural biochemical responses. Nanomaterials with pro-angiogenic sequences, anti-inflammatory sequences, and proadherence sequences can be utilized for repairing soft tissues. PBNMs can be fabricated in two and three dimensions. The high density of chemical functionality in peptides can be exploited to fabricate nanomaterials of smaller and higher dimensions, including nanoparticles and nanofibers. In the past few decades the self-assembly strategy has been utilized for preparing PBNMs with high stability and multivalency. Controlled self-assembly for fabrication of PBNMs can also be achieved by application of externally applied stimuli such as pH, light, enzyme etc. Compatibility with immune system, cell survival, restoration of mechanical properties, compositional considerations, cell exhaustion, and ethical regulations are the major challenges to be overcome for clinical translations of PBNMs. Peptide-based functional nanomaterials seem to be clinically translatable for tissue repair and regeneration and are promising biomaterials to improve quality of life at comparatively low cost. By exploiting the versatile nature of nanomaterials peptide/protein-based nanomaterials (PBNMs) may prove to be an efficient soft-tissue repair method. Peptides can be self-assembled into different nanostructures such as nanotubes, nanofibers, monolayers, nanovesicles, etc. The most popular short-peptide–based nanostructures are prepared with dipeptides for biomedical applications. Major advantages of using cyclic peptides are the precise diameter control of nanostructures and functionalization with the side chains. Amphiphilic peptides can be self-assembled into nanovesicles, nanotubes, and nanomicelles. α- helical peptides with 25–30 amino acids are found suitable by researchers for fabrication of self-assembled nanostructures. ßβ-sheet peptides are among the most useful natural peptide motifs, having alternating hydrophilic and hydrophobic amino acid sequences providing an amphiphilic nature to the peptide structure.
Assessment of an immunization program in a supermarket chain pharmacy.

J. Goode,D. Mott,Dennis D. Stanley

DOI: https://doi.org/10.1331/JAPHA.2007.06100

IF: 2.118

2007-07-01

Journal of the American Pharmacists Association

Abstract:5. The Accredited Standards Committee (ASC) X12. Subcommit-tee: X12N: insurance purpose and scope. Accessed at www.x12.org/x12org/subcommittees/sc_home.cfm?strSC=N, Janu-ary 16, 2007.6. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med. 2003;163:1813–20.7. Bluml BJ. Definition of medication therapy management: de-velopment of professionwide consensus. J Am Pharm Assoc. 2005;45:566–72.8. American Medical Association. CPT changes 2006: an insider’s view. Chicago: American Medical Association; 2005:309–12.9. American Medical Association. CPT process: how a code be-comes a code. Accessed at www.ama-assn.org/ama/pub/ category/3882.html, January 16, 2007.10. Hasio EC, Braun P, Yntema D, Beckler ER. Estimating physi-cians’ work for a resource-based relative-value scale. N Engl J Med. 1988;319:835–41.
Intra‐Articular Injectable Biomaterials: Therapeutic Delivery for Cartilage Repair and Regeneration

Manivannan Sivaperuman Kalairaj,Ridhi Pradhan,Waqas Saleem,Morgan M. Smith,Akhilesh K. Gaharwar

DOI: https://doi.org/10.1002/adhm.202303794

IF: 10

2024-02-09

Advanced Healthcare Materials

Abstract:Osteoarthritis is a degenerative joint disease characterized by cartilage deterioration and subsequent inflammatory changes in the underlying bone. Injectable hydrogels have emerged as a promising approach for controlled drug delivery in cartilage therapies. This review article focuses on the latest developments in utilizing injectable hydrogels as vehicles for precise and targeted drug delivery to promote cartilage repair and regeneration. The review begins by discussing the pathogenesis of osteoarthritis to provide a comprehensive understanding of the disease process. Subsequently, we delve into the various types of injectable hydrogels used for drug delivery to cartilage. Specifically, physically and chemically crosslinked injectable hydrogels are explored, with an emphasis on their fabrication strategies and their capacity to encapsulate and release therapeutic agents in a controlled manner. Furthermore, we discuss the potential of incorporating growth factors, anti‐inflammatory drugs, and stem cells within these hydrogel systems. We highlight their crucial roles in modulating cellular behavior, promoting cartilage regeneration, and reducing inflammation. Overall, this review offers a comprehensive guide to navigating the promising landscape of hydrogel‐based therapeutics in osteoarthritis. By providing insights into the pathogenesis of osteoarthritis and discussing the advancements in injectable hydrogels for controlled drug delivery, this review aims to enhance our understanding and foster further developments in the field of cartilage repair and regeneration. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Current Research on Pharmacologic and Regenerative Therapies for Osteoarthritis

Wei Zhang,Hongwei Ouyang,Crispin R Dass,Jiake Xu

DOI: https://doi.org/10.1038/boneres.2015.40

IF: 12.7

2016-01-01

Bone Research

Abstract:AbstractOsteoarthritis (OA) is a degenerative joint disorder commonly encountered in clinical practice, and is the leading cause of disability in elderly people. Due to the poor self-healing capacity of articular cartilage and lack of specific diagnostic biomarkers, OA is a challenging disease with limited treatment options. Traditional pharmacologic therapies such as acetaminophen, non-steroidal anti-inflammatory drugs, and opioids are effective in relieving pain but are incapable of reversing cartilage damage and are frequently associated with adverse events. Current research focuses on the development of new OA drugs (such as sprifermin/recombinant human fibroblast growth factor-18, tanezumab/monoclonal antibody against β-nerve growth factor), which aims for more effectiveness and less incidence of adverse effects than the traditional ones. Furthermore, regenerative therapies (such as autologous chondrocyte implantation (ACI), new generation of matrix-induced ACI, cell-free scaffolds, induced pluripotent stem cells (iPS cells or iPSCs), and endogenous cell homing) are also emerging as promising alternatives as they have potential to enhance cartilage repair, and ultimately restore healthy tissue. However, despite currently available therapies and research advances, there remain unmet medical needs in the treatment of OA. This review highlights current research progress on pharmacologic and regenerative therapies for OA including key advances and potential limitations.
The Therapeutic Potential of Intra-Articular Injection of Synthetic Deer Antler Peptides in a Rat Model of Knee Osteoarthritis

Yu-Chou Hung,Li-Jin Chen,Jen-Hung Wang,Tsung-Jung Ho,Guo-Fang Tseng,Hao-Ping Chen

DOI: https://doi.org/10.3390/ijms25116041

IF: 5.6

2024-05-31

International Journal of Molecular Sciences

Abstract:Synthetic deer antler peptides (TSKYR, TSK, and YR) stimulate the proliferation of human chondrocytes and osteoblasts and increase the chondrocyte content of collagen and glycosamino-glycan in vitro. This study investigated the peptide mixture's pain relief and chondroprotective effect in a rat model of collagenase-induced osteoarthritis. Thirty-six adult male Sprague–Dawley rats were divided into three groups: control (saline), positive control (hyaluronic acid), and ex-perimental (peptides). Intra-articular collagenase injections were administered on days 1 and 4 to induce osteoarthritis in the left knees of the rats. Two injections of saline, hyaluronic acid, or the peptides were injected into the same knees of each corresponding group at the beginning of week one and two, respectively. Joint swelling, arthritic pain, and histopathological changes were evaluated. Injection of the peptides significantly reduced arthritic pain compared to the control group, as evidenced by the closer-to-normal weight-bearing and paw withdrawal threshold test results. Histological analyses showed reduced cartilage matrix loss and improved total cartilage degeneration score in the experimental versus the control group. Our findings suggest that intra-articular injection of synthetic deer antler peptides is a promising treatment for osteoarthritis.

biochemistry & molecular biology,chemistry, multidisciplinary
The effects of collagen peptide supplementation on body composition, collagen synthesis, and recovery from joint injury and exercise: a systematic review

Mishti Khatri,Robert J. Naughton,Tom Clifford,Liam D. Harper,Liam Corr

DOI: https://doi.org/10.1007/s00726-021-03072-x

IF: 3.7891

2021-09-07

Amino Acids

Abstract:Abstract Collagen peptide supplementation (COL), in conjunction with exercise, may be beneficial for the management of degenerative bone and joint disorders. This is likely due to stimulatory effects of COL and exercise on the extracellular matrix of connective tissues, improving structure and load-bearing capabilities. This systematic review aims to evaluate the current literature available on the combined impact of COL and exercise. Following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, a literature search of three electronic databases—PubMed, Web of Science and CINAHL—was conducted in June 2020. Fifteen randomised controlled trials were selected after screening 856 articles. The study populations included 12 studies in recreational athletes, 2 studies in elderly participants and 1 in untrained pre-menopausal women. Study outcomes were categorised into four topics: (i) joint pain and recovery from joint injuries, (ii) body composition, (iii) muscle soreness and recovery from exercise, and (iv) muscle protein synthesis (MPS) and collagen synthesis. The results indicated that COL is most beneficial in improving joint functionality and reducing joint pain. Certain improvements in body composition, strength and muscle recovery were present. Collagen synthesis rates were elevated with 15 g/day COL but did not have a significant impact on MPS when compared to isonitrogenous higher quality protein sources. Exact mechanisms for these adaptations are unclear, with future research using larger sample sizes, elite athletes, female participants and more precise outcome measures such as muscle biopsies and magnetic imagery.

biochemistry & molecular biology
Intra-articular interventions in osteoarthritis: Navigating the landscape of hyaluronic acid, mesenchymal stem cells, and platelet-rich plasma

Somar Soufan,Joenne Al Khoury,Zahi Hamdan,Mohamad Ali Rida

DOI: https://doi.org/10.5312/wjo.v15.i8.704

2024-08-18

Abstract:Osteoarthritis (OA) poses a substantial burden on patients, leading to pain, functional decline, and reduced quality of life. While conventional treatments focus on symptom management, disease-modifying interventions are yet to be established. This review explores the efficacy of intra-articular interventions, particularly hyaluronic acid (HA), mesenchymal stem cells (MSCs), and platelet-rich plasma (PRP), in the context of OA management. HA injections, with diverse formulations like Hylan G-F20, sodium hyaluronate, and hyaluronan, present varying outcomes, necessitating a nuanced understanding of their effectiveness and timing. MSC therapy, derived from adipose tissue, umbilical cord, or bone marrow, shows promising results in clinical improvement, with adipose-derived MSCs demonstrating efficacy in maintaining benefits over 6 mo. Conversely, bone-marrow-derived MSCs show limited effectiveness, highlighting the need for source-specific considerations. PRP has emerged as a superior option for long-term pain reduction and quality of life improvement, with leukocyte-poor formulations and a critical platelet count of 10 billion demonstrating optimal results. This comprehensive analysis underscores the potential of intra-articular interventions in OA management, emphasizing the need for personalized and evidence-based approaches to enhance treatment efficacy and patient outcomes.
Clinical Applications of Naturally Derived Biopolymer-Based Scaffolds for Regenerative Medicine

Whitney L. Stoppel,Chiara E. Ghezzi,Stephanie L. McNamara,Lauren D. Black III,David L. Kaplan

DOI: https://doi.org/10.1007/s10439-014-1206-2

IF: 3.8

2014-12-24

Annals of Biomedical Engineering

Abstract:Naturally derived polymeric biomaterials, such as collagens, silks, elastins, alginates, and fibrins are utilized in tissue engineering due to their biocompatibility, bioactivity, and tunable mechanical and degradation kinetics. The use of these natural biopolymers in biomedical applications is advantageous because they do not release cytotoxic degradation products, are often processed using environmentally-friendly aqueous-based methods, and their degradation rates within biological systems can be manipulated by modifying the starting formulation or processing conditions. For these reasons, many recent in vivo investigations and FDA-approval of new biomaterials for clinical use have utilized natural biopolymers as matrices for cell delivery and as scaffolds for cell-free support of native tissues. This review highlights biopolymer-based scaffolds used in clinical applications for the regeneration and repair of native tissues, with a focus on bone, skeletal muscle, peripheral nerve, cardiac muscle, and cornea substitutes.

engineering, biomedical

Binging Knowledge to Bear: Challenges for Decision Support Databases

Injectable therapeutic peptides-an adjunct to regenerative medicine and sports performance?

Peptide-Based Biomaterials for Bone and Cartilage Regeneration

Peptides for Targeting Chondrogenic Induction and Cartilage Regeneration in Osteoarthritis

Therapeutic applications of biological macromolecules and scaffolds for skeletal muscle regeneration: A review

The Use of Platelet-Rich Plasma and Stem Cell Injections in Musculoskeletal Injuries

Therapeutic Sources of Skeletal Muscle Regeneration from Volumetric Muscle Loss: A Narrative Review

Swarm optimized organizing map (SWOM): A swarm intelligence basedoptimization of self-organizing map

Preclinical research studies for treating severe muscular injuries: focus on tissue-engineered strategies

The perio-endo question: differential diagnosis.

Cell-based therapy in soft tissue sports injuries of the knee: a systematic review

Gelatin Methacryloyl Hydrogels for Musculoskeletal Tissue Regeneration

The use of amniotic tissue-derived products in orthopedic surgery: A narrative review

Peptide-Based Functional Nanomaterials for Soft-Tissue Repair

Assessment of an immunization program in a supermarket chain pharmacy.

Intra‐Articular Injectable Biomaterials: Therapeutic Delivery for Cartilage Repair and Regeneration

Current Research on Pharmacologic and Regenerative Therapies for Osteoarthritis

The Therapeutic Potential of Intra-Articular Injection of Synthetic Deer Antler Peptides in a Rat Model of Knee Osteoarthritis

The effects of collagen peptide supplementation on body composition, collagen synthesis, and recovery from joint injury and exercise: a systematic review

Intra-articular interventions in osteoarthritis: Navigating the landscape of hyaluronic acid, mesenchymal stem cells, and platelet-rich plasma

Clinical Applications of Naturally Derived Biopolymer-Based Scaffolds for Regenerative Medicine